AF and COVID-19 share overlapping pathophysiological mechanisms driven by immune-mediated processes, with inflammatory markers such as C-reactive protein (CRP) and interleukin (IL)-6 correlating with disease severity and mortality [19]. The gene discussed is IL6; the disease is atrial fibrillation.